172 related articles for article (PubMed ID: 36734195)
1. Whole-brain radiotherapy associated with structural changes resembling aging as determined by anatomic surface-based deep learning.
Rammohan N; Ho A; Besson P; Kruser TJ; Bandt SK
Neuro Oncol; 2023 Jul; 25(7):1323-1330. PubMed ID: 36734195
[TBL] [Abstract][Full Text] [Related]
2. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
3. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study.
Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY
Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128
[TBL] [Abstract][Full Text] [Related]
5. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
[TBL] [Abstract][Full Text] [Related]
6. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
[TBL] [Abstract][Full Text] [Related]
7. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.
Popp I; Rau S; Hintz M; Schneider J; Bilger A; Fennell JT; Heiland DH; Rothe T; Egger K; Nieder C; Urbach H; Grosu AL
Cancer; 2020 Jun; 126(11):2694-2703. PubMed ID: 32142171
[TBL] [Abstract][Full Text] [Related]
8. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
[TBL] [Abstract][Full Text] [Related]
9. Treatment Planning and Delivery of Whole Brain Irradiation with Hippocampal Avoidance in Rats.
Cramer CK; Yoon SW; Reinsvold M; Joo KM; Norris H; Hood RC; Adamson JD; Klein RC; Kirsch DG; Oldham M
PLoS One; 2015; 10(12):e0143208. PubMed ID: 26636762
[TBL] [Abstract][Full Text] [Related]
10. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases.
Lebow ES; Hwang WL; Zieminski S; Wang Y; Niemierko A; Mehan WA; Oh KS; Khandekar M; Willers H; Shih HA
J Neurooncol; 2020 May; 148(1):81-88. PubMed ID: 32307637
[TBL] [Abstract][Full Text] [Related]
11. Automated contouring and planning pipeline for hippocampal-avoidant whole-brain radiotherapy.
Feng CH; Cornell M; Moore KL; Karunamuni R; Seibert TM
Radiat Oncol; 2020 Oct; 15(1):251. PubMed ID: 33126894
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imaging.
Wang BH; Hua W; Gu X; Wang XL; Li J; Liu LQ; Huang YX
Australas Phys Eng Sci Med; 2015 Dec; 38(4):767-75. PubMed ID: 26577714
[TBL] [Abstract][Full Text] [Related]
13. Volumetric modulated arc therapy (VMAT) for hippocampal-avoidance whole brain radiation therapy: planning comparison with Dual-arc and Split-arc partial-field techniques.
Yuen AHL; Wu PM; Li AKL; Mak PCY
Radiat Oncol; 2020 Feb; 15(1):42. PubMed ID: 32070385
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience.
Awad R; Fogarty G; Hong A; Kelly P; Ng D; Santos D; Haydu L
Radiat Oncol; 2013 Mar; 8():62. PubMed ID: 23497418
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.
Mahadevan A; Sampson C; LaRosa S; Floyd SR; Wong ET; Uhlmann EJ; Sengupta S; Kasper EM
Radiat Oncol; 2015 Nov; 10():245. PubMed ID: 26611656
[TBL] [Abstract][Full Text] [Related]
16. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer.
Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y
Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773
[TBL] [Abstract][Full Text] [Related]
17. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.
Popp I; Grosu AL; Fennell JT; Fischer M; Baltas D; Wiehle R
Strahlenther Onkol; 2022 Jun; 198(6):537-546. PubMed ID: 35357511
[TBL] [Abstract][Full Text] [Related]
18. Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases: Results of a retrospective analysis.
Shieh LT; Lee SW; Chen CC; Ho YC; Wang YW; Ho SY
Medicine (Baltimore); 2022 Apr; 101(14):e29144. PubMed ID: 35446298
[TBL] [Abstract][Full Text] [Related]
19. Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance.
Kim Y; Kim SH; Lee JH; Kang DG
Cancer Res Treat; 2019 Apr; 51(2):568-575. PubMed ID: 30011983
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer.
Westover KD; Mendel JT; Dan T; Kumar K; Gao A; Pulipparacharuv S; Iyengar P; Nedzi L; Hannan R; Anderson J; Choe KS; Jiang W; Abdulrahman R; Rahimi A; Folkert M; Laine A; Presley C; Cullum CM; Choy H; Ahn C; Timmerman R
Neuro Oncol; 2020 Dec; 22(12):1831-1839. PubMed ID: 32347302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]